{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:53:14Z","timestamp":1781704394109,"version":"3.54.5"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>Endometrioid intraepithelial neoplasia (EIN) is a preinvasive precursor of endometrial carcinoma, yet its recognition in secretory-phase endometrium remains diagnostically challenging. Current criteria for EIN diagnosis do not account for female reproductive physiology, including the effects of endogenous progestins on the endometrium or EIN. Because women spend a substantial proportion of reproductive life in the secretory phase, failure to recognize EIN in this context represents an important gap in early detection. We systematically analyzed 40 cases of EIN arising in unequivocal physiological secretory endometrium, excluding patients with exogenous hormone exposure or other confounding factors. All cases exhibited architectural and cytologic distinctiveness relative to the background endometrium. Paradoxically, most lesions demonstrated diminished or absent secretory differentiation, challenging prevailing assumptions. Morules were identified in 38% of cases and represented a useful diagnostic clue. Additional features, including eosinophilic cytoplasm, epithelial stratification, mitotic activity, and apoptotic bodies, were variably present and functioned as supportive but nonessential findings. Immunohistochemistry demonstrated aberrancy for at least 1 of 3 established biomarkers (PAX2, PTEN, or \u03b2-catenin) in 95% of cases, underscoring the diagnostic value of this panel in the secretory phase, whereas Ki-67 proved unreliable. Collectively, these findings delineate morphologic and immunophenotypic features of EIN in secretory phase endometrium. Because most lesions have diminished secretory differentiation, the term \u201csecretory EIN\u201d is diagnostically problematic. We recommend adoption of the term \u201cEIN in the secretory phase\u201d and emphasize that improved recognition of this entity has direct implications for diagnostic accuracy and cancer prevention.<\/jats:p>","DOI":"10.1097\/pas.0000000000002548","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:00:10Z","timestamp":1776106810000},"page":"834-848","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Endometrioid Intraepithelial Neoplasia in the Secretory Phase"],"prefix":"10.1097","volume":"50","author":[{"given":"Amanda M.","family":"Means","sequence":"first","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lucas","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Harold C. Simmons Comprehensive Cancer Center, UT Southwestern"},{"name":"Department of Pathology, Parkland Hospital, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Zhang","sequence":"additional","affiliation":[{"name":"Health Data Science and Biostatistics"},{"name":"Harold C. Simmons Comprehensive Cancer Center, UT Southwestern"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glorimar","family":"Rivera-Colon","sequence":"additional","affiliation":[{"name":"Anatomic Pathology and Cytopathology, Baylor Scott and White Health, Temple, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Niu","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Obstetrics and Gynecology"},{"name":"Harold C. Simmons Comprehensive Cancer Center, UT Southwestern"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley S.","family":"Carrick","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Gwin","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Grubman","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego H.","family":"Castrillon","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Obstetrics and Gynecology"},{"name":"Harold C. Simmons Comprehensive Cancer Center, UT Southwestern"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"R3-20260617","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/AOG.0000000000004676","article-title":"The changing landscape of gynecologic cancer mortality in the United States","volume":"139","author":"Giaquinto","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R4-20260617","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"R5-20260617","doi-asserted-by":"crossref","first-page":"526.e521","DOI":"10.1016\/j.ajog.2024.06.026","article-title":"Uterine cancer incidence trends and 5-year relative survival by race\/ethnicity and histology among women under 50 years","volume":"231","author":"Wijayabahu","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"R6-20260617","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.5888\/pcd18.210006","article-title":"Cancer incidence projections in the United States between 2015 and 2050","volume":"18","author":"Weir","year":"2021","journal-title":"Prev Chronic Dis"},{"key":"R7-20260617","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"The Lancet"},{"key":"R9-20260617","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bpobgyn.2016.09.009","article-title":"Menstrual questionnaires for clinical and research use","volume":"40","author":"Matteson","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R10-20260617","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R11-20260617","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/modpathol.2012.231","article-title":"Endometrial intraepithelial neoplasia with secretory differentiation: diagnostic features and underlying mechanisms","volume":"26","author":"Parra-Herran","year":"2013","journal-title":"Mod Pathol"},{"key":"R12-20260617","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0090-8258(02)00140-3","article-title":"Endometrial hyperplasia with secretory changes","volume":"88","author":"Tresserra","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R13-20260617","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/PGP.0000000000000115","article-title":"Endometrial hyperplasia and carcinoma with superimposed secretory changes: a double whammy","volume":"33","author":"Daya","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R14-20260617","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PGP.0000000000000160","article-title":"Secretory endometrial intraepithelial neoplasia","volume":"33","author":"Jeffus","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20260617","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/cancers17091495","article-title":"Expression characteristics of 3-marker panel (PAX2, PTEN, and \u03b2-catenin) in benign interval and secretory endometrium and secretory endometrial precancer","volume":"17","author":"Niu","year":"2025","journal-title":"Cancers (Basel)"},{"key":"R16-20260617","first-page":"77","article-title":"PCNA and Ki-67 in endometrial hyperplasias and evaluation of the potential of malignancy","volume":"32","author":"Abike","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"R17-20260617","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/PGP.0b013e3182a2945d","article-title":"Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge","volume":"33","author":"Truskinovsky","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20260617","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PGP.0000000000000092","article-title":"Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change","volume":"33","author":"Gurda","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20260617","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0015-0282(16)30062-0","article-title":"Dating the endometrial biopsy","volume":"1","author":"Noyes","year":"1950","journal-title":"Fertil Steril"},{"key":"R20-20260617","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/PAS.0000000000002034","article-title":"Beta-catenin, Pax2, and Pten panel identifies precancers among histologically subdiagnostic endometrial lesions","volume":"47","author":"Aguilar","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R21-20260617","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","article-title":"Reliable identification of endometrial precancers through combined Pax2, \u03b2-catenin, and Pten immunohistochemistry","volume":"46","author":"Aguilar","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R22-20260617","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.mpdhp.2023.07.006","article-title":"\u03b2-Catenin, PAX2 and PTEN panel in the diagnosis of endometrial precancers: a case-based review","volume":"29","author":"Lucas","year":"2023","journal-title":"Diagn Histopathol"},{"key":"R23-20260617","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.semdp.2021.12.001","article-title":"Histopathologic diagnosis of endometrial precancers: updates and future directions","volume":"39","author":"Chen","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"R24-20260617","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PGP.0000000000000583","article-title":"Clinicopathologic and immunohistochemical correlates of CTNNB1 mutated endometrial endometrioid carcinoma","volume":"39","author":"Costigan","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R25-20260617","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear beta-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","volume":"31","author":"Kim","year":"2018","journal-title":"Mod Pathol"},{"key":"R26-20260617","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0000000000002402","article-title":"Pilomatrix-like high-grade endometrial carcinoma: an underdiagnosed entity with aggressive clinicopathologic features","volume":"49","author":"Zhou","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R27-20260617","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-10-0149","article-title":"Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer","volume":"70","author":"Monte","year":"2010","journal-title":"Cancer Res"},{"key":"R28-20260617","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2023.05.061","article-title":"Association of body mass index with early age at diagnosis of endometrial intraepithelial neoplasia","volume":"175","author":"Nicholson","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R30-20260617","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R31-20260617","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"key":"R32-20260617","first-page":"20","article-title":"Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors","volume":"254","author":"Aguilar","year":"2021","journal-title":"J Pathol"},{"key":"R33-20260617","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/PAS.0000000000001934","article-title":"Morules but not squamous differentiation are a reliable indicator of CTNNB1 (beta-catenin) mutations in endometrial carcinoma and precancers","volume":"46","author":"Niu","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R34-20260617","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2559.2008.03083.x","article-title":"Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2","volume":"53","author":"Houghton","year":"2008","journal-title":"Histopathology"},{"key":"R35-20260617","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/path.856","article-title":"Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation","volume":"194","author":"Saegusa","year":"2001","journal-title":"J Pathol"},{"key":"R36-20260617","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001537","article-title":"Specific biomarker expression patterns in the diagnosis of residual and recurrent endometrial precancers after progestin treatment: a longitudinal study","volume":"44","author":"Chen","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R37-20260617","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/gyno.2000.5955","article-title":"Apoptosis may be an early event of progestin therapy for endometrial hyperplasia","volume":"79","author":"Amezcua","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R38-20260617","first-page":"232","article-title":"New concepts for an old problem: the diagnosis of endometrial hyperplasia","volume":"23","author":"Sanderson","year":"2017","journal-title":"Hum Reprod Update"},{"key":"R39-20260617","doi-asserted-by":"crossref","first-page":"e190989","DOI":"10.1172\/JCI190989","article-title":"A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis","volume":"135","author":"Sahoo","year":"2025","journal-title":"J Clin Invest"},{"key":"R40-20260617","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.semdp.2022.02.002","article-title":"Low grade endometrial endometrioid adenocarcinoma: a review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features","volume":"39","author":"Lucas","year":"2022","journal-title":"Semin Diagn Pathol"},{"key":"R41-20260617","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/PAS.0000000000002076","article-title":"Utility of a PAX2, PTEN, and beta-catenin panel in the diagnosis of atypical hyperplasia\/endometrioid intraepithelial neoplasia in endometrial polyps","volume":"47","author":"Lucas","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R42-20260617","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/his.15215","article-title":"Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia\/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome","volume":"85","author":"Wyvekens","year":"2024","journal-title":"Histopathology"},{"key":"R43-20260617","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1158\/1078-0432.CCR-09-0814","article-title":"Progesterone inhibition of Wnt\/beta-catenin signaling in normal endometrium and endometrial cancer","volume":"15","author":"Wang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R44-20260617","doi-asserted-by":"crossref","first-page":"191.e191","DOI":"10.1016\/j.ajog.2020.08.032","article-title":"Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer","volume":"224","author":"Westin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R45-20260617","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1349-7006.2003.tb01360.x","article-title":"Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy","volume":"94","author":"Saegusa","year":"2003","journal-title":"Cancer Sci"},{"key":"R46-20260617","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PGP.0000000000001008","article-title":"Predicting progestin therapy response with PTEN, PAX2, and \u03b2-catenin in patients with endometrioid precancer","volume":"43","author":"Liu","year":"2024","journal-title":"Int J Gynecol Pathol"},{"key":"R47-20260617","doi-asserted-by":"crossref","first-page":"e66034","DOI":"10.7554\/eLife.66034","article-title":"Chromatin topology defines estradiol-primed progesterone receptor and PAX2 binding in endometrial cancer cells","volume":"11","author":"La Greca","year":"2022","journal-title":"eLife"},{"key":"R48-20260617","first-page":"239","article-title":"Dyssynchronous secretory endometrial glands often show sporadically acquired progesterone nonresponsiveness","volume":"34","author":"Howitt","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"R49-20260617","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00000478-199909000-00014","article-title":"A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens","volume":"23","author":"Bergeron","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R50-20260617","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.12249","article-title":"Reproducibility of current classifications of endometrial endometrioid glandular proliferations: further evidence supporting a simplified classification","volume":"64","author":"Ordi","year":"2014","journal-title":"Histopathology"},{"key":"R51-20260617","doi-asserted-by":"crossref","first-page":"e0302252","DOI":"10.1371\/journal.pone.0302252","article-title":"Factors associated with interobserver variation amongst pathologists in the diagnosis of endometrial hyperplasia: a systematic review","volume":"19","author":"McCoy","year":"2024","journal-title":"PLoS One"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:03:57Z","timestamp":1781701437000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002548"}},"subtitle":["Morphologic and Biomarker Diagnostic Features in a Common, Overlooked Setting"],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002548","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"2026-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}